CG Oncology, Inc. Common stock (CGON) — Financial Flexibility Index
CG Oncology, Inc. Common stock (CGON) has a Financial Flexibility Index of -0.93x as of December 2025. Free cash flow of $-36.21 Million (operating CF $-36.22 Million minus capex $7.00K) represents -1% of total liabilities ($38.99 Million). Also explore CGON year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CG Oncology, Inc. Common stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CG Oncology, Inc. Common stock across 5 annual periods. Check CG Oncology, Inc. Common stock liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for CG Oncology, Inc. Common stock (2021–2025)
Year-by-year free cash flow to debt coverage for CG Oncology, Inc. Common stock. For the full company profile including market capitalisation, see CG Oncology, Inc. Common stock (CGON) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.39x | $-132.21 Million | $-132.35 Million | $38.99 Million | ▲ +7.4% |
| 2024 | -3.66x | $-78.48 Million | $-78.71 Million | $21.42 Million | ▼ -16.4% |
| 2023 | -3.15x | $-45.68 Million | $-45.68 Million | $14.51 Million | ▼ -138.5% |
| 2022 | -1.32x | $-29.79 Million | $-29.80 Million | $22.57 Million | ▼ -79.5% |
| 2021 | -0.74x | $-13.56 Million | $-13.65 Million | $18.44 Million | — |